Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Togashi

Showing results (31-40 of 156) with videos related to

Pageof 16
Sort By:
Oncotarget|July 23, 2014
KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survivalMasato Terashima, Yoshihiko Fujita, Yosuke Togashi, et al.
Cancer Immunology Research|April 16, 2023
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway DefectsKatsushige Kawase, Shusuke Kawashima, Joji Nagasaki, et al.
Cancer Immunology Research|July 31, 2025
PI3K/Akt signaling pathway regulates CD155 expression involved in resistance to cancer immunotherapyKatsushige Kawase, Shusuke Kawashima, Tatsuya Nishi, et al.
Springerplus|August 21, 2014
Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell linesMasato Terashima, Kazuko Sakai, Yosuke Togashi, et al.
Cancer Science|February 10, 2023
Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunityTomofumi Watanabe, Takamasa Ishino, Youki Ueda, et al.
Oncology|February 1, 2013
Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapyKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
Medical Oncology (Northwood, London, England)|July 23, 2011
Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinibKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
The Journal of Investigative Dermatology|January 27, 2019
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 TherapyTakashi Inozume, Tomonori Yaguchi, Ryo Ariyasu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutationJunko Tanizaki, Eri Banno, Yosuke Togashi, et al.
Cancer Science|July 24, 2023
Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse modelsNaoya Kemmotsu, Li Zhu, Joji Nagasaki, et al.
Pageof 16

Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Oncotarget|July 23, 2014
KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survivalMasato Terashima, Yoshihiko Fujita, Yosuke Togashi, et al.
Cancer Immunology Research|April 16, 2023
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway DefectsKatsushige Kawase, Shusuke Kawashima, Joji Nagasaki, et al.
Cancer Immunology Research|July 31, 2025
PI3K/Akt signaling pathway regulates CD155 expression involved in resistance to cancer immunotherapyKatsushige Kawase, Shusuke Kawashima, Tatsuya Nishi, et al.
Springerplus|August 21, 2014
Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell linesMasato Terashima, Kazuko Sakai, Yosuke Togashi, et al.
Cancer Science|February 10, 2023
Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunityTomofumi Watanabe, Takamasa Ishino, Youki Ueda, et al.
Oncology|February 1, 2013
Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapyKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
Medical Oncology (Northwood, London, England)|July 23, 2011
Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinibKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
The Journal of Investigative Dermatology|January 27, 2019
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 TherapyTakashi Inozume, Tomonori Yaguchi, Ryo Ariyasu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutationJunko Tanizaki, Eri Banno, Yosuke Togashi, et al.
Cancer Science|July 24, 2023
Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse modelsNaoya Kemmotsu, Li Zhu, Joji Nagasaki, et al.
Pageof 16